Money Follows the Person Rebalancing Grant Demonstration Program
Page 2

And in the process, the program also seeks to achieve the following objectives:

a) Increase the use of Home and Community Based Services (HCBS) and reduce the use of institutionally-based services;

b) Eliminate barriers and mechanisms in State law, State Medicaid plans, or State budgets that prevent or restrict the flexible use of Medicaid funds to enable Medicaid-eligible individuals to receive long-term care in the settings of their choice;

c) Strengthen the ability of Medicaid programs to assure continued provision of HCBS to those individuals who choose to transition from institutions;

d) Ensure that procedures are in their proper places to provide quality assurance and continuous quality
improvement of HCBS.

In order to support these initiatives, the Centers for Medicare & Medicaid Services is ready to administer funds in the amount of $1,700,000.

The CMS has stipulated that any State Medicaid Agency not currently participating in the MFP Rebalancing Demonstration may submit an application under the Money Follows the Person Rebalancing Grant Demonstration Program.

The United States Department of Health and Human Services, the mother agency funding the Money Follows the Person Rebalancing Grant Demonstration Program, is the country's leading agency that is responsible for protecting the health of all Americans through the provision of essential human services to everyone, especially to those who are vulnerable and medically challenged.

Money Follows the Person Rebalancing Grant Demonstration Program
  Back to Page 1

About The Author Michael Saunders is an editor of TopGovernmentGrants.com one the the most comprehensive Websites offering information on government grants and federal government programs. He also maintains Websites providing resources on environmental grants and grants for youth programs.

Additional Resources

category - Health Grants

Development of Therapeutics and Diagnostics for Biodefense Program
The National Institutes of Health, in partnership with the National Institute of Allergy and Infectious Diseases(NIAID), has established the Development of Therapeutics and Diagnostics for Biodefense Program in an attempt to seek research proposals that desire to support the development of lead candidate diagnostics or therapeutics against NIAID Category A, B, or C priority agents.

---

Advanced Neural Prosthetics Research and Development Program
The National Institutes of Health has formed a partnership with the National Institute of Neurological Disorders and Stroke (NINDS) and the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to establish the Advanced Neural Prosthetics Research and Development Program.

---

Strategic Alliances for Medications Development to Treat Substance Use Disorder Program
The National Institutes of Health, in cooperation with the National Institute on Drug Abuse (NIDA), has recently established the Strategic Alliances for Medications Development to Treat Substance Use Disorder Program wherein both agencies seek to support the development of substance abuse drugs by leveraging the strengths of two or more organizations toward a common goal of medications development.

---

Early-Stage Innovative Technology Development for Cancer Research Program
The National Institutes of Health has collaborated with the National Cancer Institute(NCI) in order to establish Early-Stage Innovative Technology Development for Cancer Research Program, wherein both agencies intend to solicit grant applications expressing intents to conduct funded exploratory research projects that concentrate on the inception and development unique, innovative technological advances that could potentially be utilized in the study of cancer.

---